Resources Contact Us Home
Modified factor VIII

Image Number 4 for United States Patent #7012132.

Specific amino acid loci of human factor VIII interact with inhibitory antibodies of hemophilia patients who have developed such antibodies after being treated with factor VIII. Modified factor VIII is disclosed in which the amino acid sequence is changed by a substitution at one or more of the specific loci. The modified factor VIII is not inhibited by inhibitory antibodies against the A2 or C2 domain epitopes. The modified factor VIII is useful for hemophiliacs, either to avoid or prevent the action of inhibitory antibodies.

  Recently Added Patents
Information repository search system
Magnetic resonance imaging apparatus
Inspection tool for top guides of a boiling water reactor
Display device and method of repairing display device
Data processor with virtual machine management
Herbal composition for the treatment of wound healing, a regenerative medicine
High voltage circuit for electrical stimulation
  Randomly Featured Patents
Slip-on face shield
Method for locating the longitudinal position of wheels of a vehicle
Cleaning tool
Methods of forming bipolar junction transistors having preferred base electrode extensions and transistors formed thereby
Ornamental design for a golf tee off clock case
Fluid control device for a gas chromatograph
Near-field tomography
Trigger switch